We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Drug giants fail to name compounds in trial database.
- Authors
Wadman, Meredith
- Abstract
The article reports that an international group of medical editors is challenging several leading pharmaceutical companies, saying that their reporting of clinical trials is deliberately incomplete. They argue that leading pharmaceutical companies are obeying the letter but not the spirit of a 1997 law that requires the public registration of ongoing trials involving serious or life-threatening illnesses. The government-maintained registry, www.clinicaltrials.gov, is intended to help patients find information about clinical trials.
- Subjects
MEDICAL editing; CLINICAL trials; PHARMACEUTICAL industry; DRUGS; MEDICAL research; PATIENTS
- Publication
Nature, 2005, Vol 435, Issue 7042, p548
- ISSN
0028-0836
- Publication type
Article
- DOI
10.1038/435548b